Figure 1 | Scientific Reports

Figure 1

From: Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment

Figure 1The alternative text for this image may have been generated using AI.

Expression analysis and survival analysis for FCGBP in HNSC. (A) The expression of FCGBP in pan-cancer based on TCGA cohort. (B) Immunohistochemistry results of FCGBP in cancer and normal tissues. (C–E) The overall survival (OS), disease specific survival (DSS), Progress Free Interval (PFI) analysis in patients with HNSC. (F–K) Expression analysis on different OS event (F), DSS event (G), PFI (H), T stage (I), lymphnode neck dissection (J), primary therapy outcome (K).

Back to article page